Cell-Based Immunotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapy (Autologous Cellular Immunotherapy, Chimeric Antigen Receptor (CAR) T-Cell Therapy, Dendritic Cell-based Vaccine Therapy); Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Others)
Report Code: TIPRE00015536 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell-Based Immunotherapy Market - By Therapy
1.3.2 Cell-Based Immunotherapy Market - By Indication
1.3.3 Cell-Based Immunotherapy Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL-BASED IMMUNOTHERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL-BASED IMMUNOTHERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL-BASED IMMUNOTHERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL-BASED IMMUNOTHERAPY - GLOBAL MARKET OVERVIEW
6.2. CELL-BASED IMMUNOTHERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL-BASED IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. AUTOLOGOUS CELLULAR IMMUNOTHERAPY
7.3.1. Overview
7.3.2. Autologous Cellular Immunotherapy Market Forecast and Analysis
7.4. CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
7.4.1. Overview
7.4.2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast and Analysis
7.5. DENDRITIC CELL-BASED VACCINE THERAPY
7.5.1. Overview
7.5.2. Dendritic Cell-based Vaccine Therapy Market Forecast and Analysis
8. CELL-BASED IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. B-CELL MALIGNANCIES
8.3.1. Overview
8.3.2. B-cell Malignancies Market Forecast and Analysis
8.4. PROSTATE CANCER
8.4.1. Overview
8.4.2. Prostate Cancer Market Forecast and Analysis
8.5. RENAL CELL CARCINOMA
8.5.1. Overview
8.5.2. Renal Cell Carcinoma Market Forecast and Analysis
8.6. LIVER CANCER
8.6.1. Overview
8.6.2. Liver Cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CELL-BASED IMMUNOTHERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cell-Based Immunotherapy Market Overview
9.1.2 North America Cell-Based Immunotherapy Market Forecasts and Analysis
9.1.3 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.1.4 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.1.5 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cell-Based Immunotherapy Market
9.1.5.1.1 United States Cell-Based Immunotherapy Market by Therapy
9.1.5.1.2 United States Cell-Based Immunotherapy Market by Indication
9.1.5.2 Canada Cell-Based Immunotherapy Market
9.1.5.2.1 Canada Cell-Based Immunotherapy Market by Therapy
9.1.5.2.2 Canada Cell-Based Immunotherapy Market by Indication
9.1.5.3 Mexico Cell-Based Immunotherapy Market
9.1.5.3.1 Mexico Cell-Based Immunotherapy Market by Therapy
9.1.5.3.2 Mexico Cell-Based Immunotherapy Market by Indication
9.2. EUROPE
9.2.1 Europe Cell-Based Immunotherapy Market Overview
9.2.2 Europe Cell-Based Immunotherapy Market Forecasts and Analysis
9.2.3 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.2.4 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.2.5 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cell-Based Immunotherapy Market
9.2.5.1.1 Germany Cell-Based Immunotherapy Market by Therapy
9.2.5.1.2 Germany Cell-Based Immunotherapy Market by Indication
9.2.5.2 France Cell-Based Immunotherapy Market
9.2.5.2.1 France Cell-Based Immunotherapy Market by Therapy
9.2.5.2.2 France Cell-Based Immunotherapy Market by Indication
9.2.5.3 Italy Cell-Based Immunotherapy Market
9.2.5.3.1 Italy Cell-Based Immunotherapy Market by Therapy
9.2.5.3.2 Italy Cell-Based Immunotherapy Market by Indication
9.2.5.4 Spain Cell-Based Immunotherapy Market
9.2.5.4.1 Spain Cell-Based Immunotherapy Market by Therapy
9.2.5.4.2 Spain Cell-Based Immunotherapy Market by Indication
9.2.5.5 United Kingdom Cell-Based Immunotherapy Market
9.2.5.5.1 United Kingdom Cell-Based Immunotherapy Market by Therapy
9.2.5.5.2 United Kingdom Cell-Based Immunotherapy Market by Indication
9.2.5.6 Rest of Europe Cell-Based Immunotherapy Market
9.2.5.6.1 Rest of Europe Cell-Based Immunotherapy Market by Therapy
9.2.5.6.2 Rest of Europe Cell-Based Immunotherapy Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cell-Based Immunotherapy Market Overview
9.3.2 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis
9.3.3 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cell-Based Immunotherapy Market
9.3.5.1.1 Australia Cell-Based Immunotherapy Market by Therapy
9.3.5.1.2 Australia Cell-Based Immunotherapy Market by Indication
9.3.5.2 China Cell-Based Immunotherapy Market
9.3.5.2.1 China Cell-Based Immunotherapy Market by Therapy
9.3.5.2.2 China Cell-Based Immunotherapy Market by Indication
9.3.5.3 India Cell-Based Immunotherapy Market
9.3.5.3.1 India Cell-Based Immunotherapy Market by Therapy
9.3.5.3.2 India Cell-Based Immunotherapy Market by Indication
9.3.5.4 Japan Cell-Based Immunotherapy Market
9.3.5.4.1 Japan Cell-Based Immunotherapy Market by Therapy
9.3.5.4.2 Japan Cell-Based Immunotherapy Market by Indication
9.3.5.5 South Korea Cell-Based Immunotherapy Market
9.3.5.5.1 South Korea Cell-Based Immunotherapy Market by Therapy
9.3.5.5.2 South Korea Cell-Based Immunotherapy Market by Indication
9.3.5.6 Rest of Asia-Pacific Cell-Based Immunotherapy Market
9.3.5.6.1 Rest of Asia-Pacific Cell-Based Immunotherapy Market by Therapy
9.3.5.6.2 Rest of Asia-Pacific Cell-Based Immunotherapy Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cell-Based Immunotherapy Market Overview
9.4.2 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis
9.4.3 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cell-Based Immunotherapy Market
9.4.5.1.1 South Africa Cell-Based Immunotherapy Market by Therapy
9.4.5.1.2 South Africa Cell-Based Immunotherapy Market by Indication
9.4.5.2 Saudi Arabia Cell-Based Immunotherapy Market
9.4.5.2.1 Saudi Arabia Cell-Based Immunotherapy Market by Therapy
9.4.5.2.2 Saudi Arabia Cell-Based Immunotherapy Market by Indication
9.4.5.3 U.A.E Cell-Based Immunotherapy Market
9.4.5.3.1 U.A.E Cell-Based Immunotherapy Market by Therapy
9.4.5.3.2 U.A.E Cell-Based Immunotherapy Market by Indication
9.4.5.4 Rest of Middle East and Africa Cell-Based Immunotherapy Market
9.4.5.4.1 Rest of Middle East and Africa Cell-Based Immunotherapy Market by Therapy
9.4.5.4.2 Rest of Middle East and Africa Cell-Based Immunotherapy Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cell-Based Immunotherapy Market Overview
9.5.2 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis
9.5.3 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cell-Based Immunotherapy Market
9.5.5.1.1 Brazil Cell-Based Immunotherapy Market by Therapy
9.5.5.1.2 Brazil Cell-Based Immunotherapy Market by Indication
9.5.5.2 Argentina Cell-Based Immunotherapy Market
9.5.5.2.1 Argentina Cell-Based Immunotherapy Market by Therapy
9.5.5.2.2 Argentina Cell-Based Immunotherapy Market by Indication
9.5.5.3 Rest of South and Central America Cell-Based Immunotherapy Market
9.5.5.3.1 Rest of South and Central America Cell-Based Immunotherapy Market by Therapy
9.5.5.3.2 Rest of South and Central America Cell-Based Immunotherapy Market by Indication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL-BASED IMMUNOTHERAPY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CELL-BASED IMMUNOTHERAPY MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENENTECH USA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMGEN INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-RAD LABORATORIES, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell-Based Immunotherapy Market - By Therapy
1.3.2 Cell-Based Immunotherapy Market - By Indication
1.3.3 Cell-Based Immunotherapy Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL-BASED IMMUNOTHERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL-BASED IMMUNOTHERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL-BASED IMMUNOTHERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL-BASED IMMUNOTHERAPY - GLOBAL MARKET OVERVIEW
6.2. CELL-BASED IMMUNOTHERAPY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL-BASED IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. AUTOLOGOUS CELLULAR IMMUNOTHERAPY
7.3.1. Overview
7.3.2. Autologous Cellular Immunotherapy Market Forecast and Analysis
7.4. CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
7.4.1. Overview
7.4.2. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast and Analysis
7.5. DENDRITIC CELL-BASED VACCINE THERAPY
7.5.1. Overview
7.5.2. Dendritic Cell-based Vaccine Therapy Market Forecast and Analysis
8. CELL-BASED IMMUNOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. B-CELL MALIGNANCIES
8.3.1. Overview
8.3.2. B-cell Malignancies Market Forecast and Analysis
8.4. PROSTATE CANCER
8.4.1. Overview
8.4.2. Prostate Cancer Market Forecast and Analysis
8.5. RENAL CELL CARCINOMA
8.5.1. Overview
8.5.2. Renal Cell Carcinoma Market Forecast and Analysis
8.6. LIVER CANCER
8.6.1. Overview
8.6.2. Liver Cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CELL-BASED IMMUNOTHERAPY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cell-Based Immunotherapy Market Overview
9.1.2 North America Cell-Based Immunotherapy Market Forecasts and Analysis
9.1.3 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.1.4 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.1.5 North America Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cell-Based Immunotherapy Market
9.1.5.1.1 United States Cell-Based Immunotherapy Market by Therapy
9.1.5.1.2 United States Cell-Based Immunotherapy Market by Indication
9.1.5.2 Canada Cell-Based Immunotherapy Market
9.1.5.2.1 Canada Cell-Based Immunotherapy Market by Therapy
9.1.5.2.2 Canada Cell-Based Immunotherapy Market by Indication
9.1.5.3 Mexico Cell-Based Immunotherapy Market
9.1.5.3.1 Mexico Cell-Based Immunotherapy Market by Therapy
9.1.5.3.2 Mexico Cell-Based Immunotherapy Market by Indication
9.2. EUROPE
9.2.1 Europe Cell-Based Immunotherapy Market Overview
9.2.2 Europe Cell-Based Immunotherapy Market Forecasts and Analysis
9.2.3 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.2.4 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.2.5 Europe Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cell-Based Immunotherapy Market
9.2.5.1.1 Germany Cell-Based Immunotherapy Market by Therapy
9.2.5.1.2 Germany Cell-Based Immunotherapy Market by Indication
9.2.5.2 France Cell-Based Immunotherapy Market
9.2.5.2.1 France Cell-Based Immunotherapy Market by Therapy
9.2.5.2.2 France Cell-Based Immunotherapy Market by Indication
9.2.5.3 Italy Cell-Based Immunotherapy Market
9.2.5.3.1 Italy Cell-Based Immunotherapy Market by Therapy
9.2.5.3.2 Italy Cell-Based Immunotherapy Market by Indication
9.2.5.4 Spain Cell-Based Immunotherapy Market
9.2.5.4.1 Spain Cell-Based Immunotherapy Market by Therapy
9.2.5.4.2 Spain Cell-Based Immunotherapy Market by Indication
9.2.5.5 United Kingdom Cell-Based Immunotherapy Market
9.2.5.5.1 United Kingdom Cell-Based Immunotherapy Market by Therapy
9.2.5.5.2 United Kingdom Cell-Based Immunotherapy Market by Indication
9.2.5.6 Rest of Europe Cell-Based Immunotherapy Market
9.2.5.6.1 Rest of Europe Cell-Based Immunotherapy Market by Therapy
9.2.5.6.2 Rest of Europe Cell-Based Immunotherapy Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cell-Based Immunotherapy Market Overview
9.3.2 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis
9.3.3 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cell-Based Immunotherapy Market
9.3.5.1.1 Australia Cell-Based Immunotherapy Market by Therapy
9.3.5.1.2 Australia Cell-Based Immunotherapy Market by Indication
9.3.5.2 China Cell-Based Immunotherapy Market
9.3.5.2.1 China Cell-Based Immunotherapy Market by Therapy
9.3.5.2.2 China Cell-Based Immunotherapy Market by Indication
9.3.5.3 India Cell-Based Immunotherapy Market
9.3.5.3.1 India Cell-Based Immunotherapy Market by Therapy
9.3.5.3.2 India Cell-Based Immunotherapy Market by Indication
9.3.5.4 Japan Cell-Based Immunotherapy Market
9.3.5.4.1 Japan Cell-Based Immunotherapy Market by Therapy
9.3.5.4.2 Japan Cell-Based Immunotherapy Market by Indication
9.3.5.5 South Korea Cell-Based Immunotherapy Market
9.3.5.5.1 South Korea Cell-Based Immunotherapy Market by Therapy
9.3.5.5.2 South Korea Cell-Based Immunotherapy Market by Indication
9.3.5.6 Rest of Asia-Pacific Cell-Based Immunotherapy Market
9.3.5.6.1 Rest of Asia-Pacific Cell-Based Immunotherapy Market by Therapy
9.3.5.6.2 Rest of Asia-Pacific Cell-Based Immunotherapy Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cell-Based Immunotherapy Market Overview
9.4.2 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis
9.4.3 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cell-Based Immunotherapy Market
9.4.5.1.1 South Africa Cell-Based Immunotherapy Market by Therapy
9.4.5.1.2 South Africa Cell-Based Immunotherapy Market by Indication
9.4.5.2 Saudi Arabia Cell-Based Immunotherapy Market
9.4.5.2.1 Saudi Arabia Cell-Based Immunotherapy Market by Therapy
9.4.5.2.2 Saudi Arabia Cell-Based Immunotherapy Market by Indication
9.4.5.3 U.A.E Cell-Based Immunotherapy Market
9.4.5.3.1 U.A.E Cell-Based Immunotherapy Market by Therapy
9.4.5.3.2 U.A.E Cell-Based Immunotherapy Market by Indication
9.4.5.4 Rest of Middle East and Africa Cell-Based Immunotherapy Market
9.4.5.4.1 Rest of Middle East and Africa Cell-Based Immunotherapy Market by Therapy
9.4.5.4.2 Rest of Middle East and Africa Cell-Based Immunotherapy Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cell-Based Immunotherapy Market Overview
9.5.2 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis
9.5.3 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Cell-Based Immunotherapy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cell-Based Immunotherapy Market
9.5.5.1.1 Brazil Cell-Based Immunotherapy Market by Therapy
9.5.5.1.2 Brazil Cell-Based Immunotherapy Market by Indication
9.5.5.2 Argentina Cell-Based Immunotherapy Market
9.5.5.2.1 Argentina Cell-Based Immunotherapy Market by Therapy
9.5.5.2.2 Argentina Cell-Based Immunotherapy Market by Indication
9.5.5.3 Rest of South and Central America Cell-Based Immunotherapy Market
9.5.5.3.1 Rest of South and Central America Cell-Based Immunotherapy Market by Therapy
9.5.5.3.2 Rest of South and Central America Cell-Based Immunotherapy Market by Indication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL-BASED IMMUNOTHERAPY MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CELL-BASED IMMUNOTHERAPY MARKET, KEY COMPANY PROFILES
12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GENENTECH USA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. AMGEN INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAYER AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILLY AND COMPANY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIO-RAD LABORATORIES, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. AbbVie Inc.
2. Genentech USA, Inc.
3. Amgen Inc
4. Bayer AG
5. Boehringer Ingelheim International GmbH.
6. Eli Lilly and Company
7. GlaxoSmithKline plc.
8. Novartis AG
9. Pfizer Inc
10. Bio-Rad Laboratories, Inc
1. AbbVie Inc.
2. Genentech USA, Inc.
3. Amgen Inc
4. Bayer AG
5. Boehringer Ingelheim International GmbH.
6. Eli Lilly and Company
7. GlaxoSmithKline plc.
8. Novartis AG
9. Pfizer Inc
10. Bio-Rad Laboratories, Inc
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount